Oxidation-Sensitive Dextran-Based Polymer with Improved Processability through Stable Boronic Ester Groups.

Particulate immunotherapy holds promise to vaccinate or treat a broad array of illnesses, including cancer, infectious diseases, and autoimmune disorders. The rate of antigen release from nano/microparticles (MPs) can impact both the type and quality of the immune response they elicit. The lysosomes of antigen-presenting cells are highly oxidizing.